Vanda Pharmaceuticals, Inc. v. FDA
D.C. Circuit Vacates FDA Denial of Citizen Petition on Generic Drug Approval
D.C. Circuit · 2025-08-15 · Remanded · Impact: 75/100
Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a remanded outcome. The D.C. Circuit reviewed the FDA's denial of Vanda Pharmaceuticals' citizen petition se...